Entresto 97 MG-103 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FRVSQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,607
Award facts
- Contract value 100% obligated
- $28,607.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,607.13 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180 count) on April 22, 2025, with an ultimate completion date of April 23, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's federal contract portfolio demonstrates extensive experience fulfilling military and veteran healthcare pharmaceutical needs, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Entresto, a cardiac medication, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems through flexible, competitively awarded contract vehicles.
Quick answers
Who was awarded contract SPE2DB25FRVSQ?
SPE2DB25FRVSQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 22, 2025.
How much is contract SPE2DB25FRVSQ worth?
The government has obligated $28,607 on SPE2DB25FRVSQ.
Is contract SPE2DB25FRVSQ an order under another contract?
Yes. SPE2DB25FRVSQ is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FRVSQ competed?
The extent of competition for SPE2DB25FRVSQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award